TIRZ — Dual GIP/GLP-1 Receptor Agonist Research Compound | Canada

TIRZ is a dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist studied in metabolic and endocrine research. Its dual-receptor mechanism has generated significant academic interest, with research examining its distinct signalling properties compared to single-receptor GLP-1 agonists in pancreatic, adipose, and hypothalamic tissue contexts.

Supplied as sterile lyophilized powder for laboratory and in vitro research applications. Each batch is independently third-party tested.

Formulation:

• Size: Available in multiple quantities
• Purity: ≥99%
• Form: Sterile lyophilized powder
• Storage: −20°C recommended

Disclaimer: For research purposes only. Not for human consumption. Not intended to diagnose, treat, cure, or prevent any disease. Sold exclusively to qualified researchers and laboratory professionals. PeptiLab products are not approved by Health Canada or the FDA for human use. Each batch is independently third-party tested for purity and identity; Certificates of Analysis are available on request.